Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

The Hajj: updated health hazards and current recommendations for 2012.

Al-Tawfiq JA, Memish ZA.

Euro Surveill. 2012 Oct 11;17(41):20295.

2.

Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine.

Shibl A, Tufenkeji H, Khalil M, Memish Z; Meningococcal Leadership Forum (MLF) Expert Group..

East Mediterr Health J. 2013 Apr;19(4):389-92.

PMID:
23882966
3.

Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011.

Memish Z, Al Hakeem R, Al Neel O, Danis K, Jasir A, Eibach D.

Euro Surveill. 2013 Sep 12;18(37). pii: 20581.

4.

Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination.

Balkhy HH, Memish ZA, Bafaqeer S, Almuneef MA.

J Travel Med. 2004 Mar-Apr;11(2):82-6.

5.

Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: A 10-year retrospective analysis of data.

Alfelali M, Barasheed O, Tashani M, Azeem MI, El Bashir H, Memish ZA, Heron L, Khandaker G, Booy R, Rashid H; Hajj Research Team..

Vaccine. 2015 May 21;33(22):2562-9. doi: 10.1016/j.vaccine.2015.04.006.

PMID:
25887084
6.

Meningococcal disease and travel.

Wilder-Smith A, Memish Z.

Int J Antimicrob Agents. 2003 Feb;21(2):102-6. Review.

PMID:
12615371
7.

Health requirements for pilgrims attending the Hajj in Mecca, Kingdom of Saudi Arabia, 24-29 October 2012.

Eurosurveillance editorial team..

Euro Surveill. 2012 Sep 13;17(37). pii: 20273. No abstract available.

8.

Meningococcal disease and prevention at the Hajj.

Borrow R.

Travel Med Infect Dis. 2009 Jul;7(4):219-25. doi: 10.1016/j.tmaid.2009.05.003.

PMID:
19717104
10.

Meningococcal carriage in Umra pilgrims returning from Saudi Arabia.

Wilder-Smith A, Paton NI, Barkham TM, Earnest A.

J Travel Med. 2003 May-Jun;10(3):147-9.

11.

Influenza and meningococcal disease: lessons for travellers and government from 2 epidemic diseases.

Booy R, El Bashir H, Rashid H, Shingadia D, Haworth E.

Travel Med Infect Dis. 2009 Jul;7(4):253-6. doi: 10.1016/j.tmaid.2008.09.001.

PMID:
19717110
12.

Health conditions for travellers to Saudi Arabia pilgrimage to Mecca (Hajj).

World Health Organization..

Wkly Epidemiol Rec. 2005 Dec 9;80(49-50):431-2. English, French. No abstract available.

PMID:
16372666
13.

Neisseria meningitidis W-135 carriage during the Hajj season 2003.

Balkhy HH, Memish ZA, Almuneef MA, Osoba AO.

Scand J Infect Dis. 2004;36(4):264-8.

PMID:
15198182
14.

Meningococcal disease and travel.

Memish ZA.

Clin Infect Dis. 2002 Jan 1;34(1):84-90.

15.

Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf Cooperation Council States.

Memish ZA, Shibl AM.

Travel Med Infect Dis. 2011 Mar;9(2):60-6. doi: 10.1016/j.tmaid.2011.01.004.

PMID:
21345738
16.

Meningococcal disease: risk for international travellers and vaccine strategies.

Wilder-Smith A.

Travel Med Infect Dis. 2008 Jul;6(4):182-6. doi: 10.1016/j.tmaid.2007.10.002.

PMID:
18571105
17.

Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.

Khalil MK, Borrow R.

Travel Med Infect Dis. 2009 Jul;7(4):231-4. doi: 10.1016/j.tmaid.2009.07.001.

PMID:
19717106
18.

Hajj 2007: vaccination requirements and travel advice issued.

Editorial team..

Euro Surveill. 2006 Nov 30;11(11):E061130.1. No abstract available.

PMID:
17213559
19.

Twin Ebola outbreaks in Africa: Uganda and Democratic Republic of Congo affected.

Bhaumik S.

Natl Med J India. 2012 Sep-Oct;25(5):317. No abstract available.

PMID:
23448651
20.

W135 meningococcal carriage in association with the Hajj pilgrimage 2001: the Singapore experience.

Wilder-Smith A.

Int J Antimicrob Agents. 2003 Feb;21(2):112-5.

PMID:
12615373
Items per page

Supplemental Content

Support Center